Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested
Psoriasis Clinical Trials
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested
Dermatology Clinical Trials
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested
Pediatric Dermatology Clinical Trials
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested
The Effect of Exercise on Muscle Dysfunction in Cystinosis
Classification of activity tolerance is of importance in chronic progressive myopathies, not only to better understand functional implications of the disease state itself, but also for purposes of exercise prescription for health maintenance. Maximal exercise testing has been considered as the gold standard of assessing maximal aerobic capacity, however testing in individuals with neuromuscular disease is often limited due to pain, activity intolerance, musculoskeletal impairments, fatigue and other such related variables. Often, submaximal exercise testing can overcome some of these obstacles, and as such, is used frequently in the clinical environment. Non-ambulatory exercise testing utilizing an arm ergometer specifically has not been studied as heavily, especially in those with progressive myopathies. For this study, we will use maximal aerobic capacity testing for individuals with Cystinosis Myopathy utilizing a bike ergometer to allow testing of individuals regardless of their ambulatory status.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: HIIT Exercise
Eligibility
Inclusion Criteria:
>=18 years -<= 60 years male or female with documented diagnosis of Cystinosis
Exclusion Criteria:
All Cystinosis participants:
- female subject who is known or suspected to be pregnant
- excluded for other illnesses or medications that may impact growth, nutritional
status, development, or bone health unrelated to cystinosis
Exercise intervention:
- exercise limitation due to pre-existing heart disease
- individuals on medications that limit heart rate (beta adrenergic blockers)
- unable to plantar flex or dorsiflex ankle against resistance
- unable to use pedal ergometer
Ages Eligible for Study
18 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tina Duong, MPT, PHDc
703-855-9677
I'm interested